We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73B
AUM Growth
-$32.7M
Cap. Flow
-$304M
Cap. Flow %
-5.3%
Top 10 Hldgs %
52.96%
Holding
258
New
61
Increased
37
Reduced
51
Closed
64

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$103M
2
AMZN icon
Amazon
AMZN
+$91.5M
3
BIIB icon
Biogen
BIIB
+$49.7M
4
PARA
Paramount Global Class B
PARA
+$49.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$48.3M

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$101M
2
ROST icon
Ross Stores
ROST
+$100M
3
FIVE icon
Five Below
FIVE
+$76.2M
4
LULU icon
lululemon athletica
LULU
+$76.1M
5
INCY icon
Incyte
INCY
+$73M

Sector Composition

Rank Sector Weight
1 Healthcare 45.98%
2 Consumer Staples 5.76%
3 Technology 4.46%
4 Consumer Discretionary 4.37%
5 Communication Services 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRDX
151
GridAI Technologies Corp
GRDX
$19.5M
$257K ﹤0.01%
+700
New +$280K
YYAI icon
152
AiRWA Inc
YYAI
$113K
$238K ﹤0.01%
1
– –
SNES icon
153
SenesTech
SNES
$8.64M
$223K ﹤0.01%
+601
New +$271K
SCNX
154
Scienture Holdings
SCNX
$15.8M
$207K ﹤0.01%
+34,333
New +$367K
INM icon
155
InMed Pharmaceuticals
INM
$7.48M
$196K ﹤0.01%
4,858
+358
+8% +$24.1K
SKYAW
156
SkyAI Inc
SKYAW
$255K
$153K ﹤0.01%
1,176,000
– –
RKDA icon
157
Arcadia Biosciences
RKDA
$1.53M
$146K ﹤0.01%
13,437
-26,849
-67% -$382K
NLSPW
158
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$145K ﹤0.01%
500,000
– –
SBEV.WS
159
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$136K ﹤0.01%
904,000
– –
MTEKW icon
160
Maris-Tech Ltd Warrants
MTEKW
$1.16M
$126K ﹤0.01%
1,261,058
– –
ONFOW icon
161
Onfolio Holdings Warrant
ONFOW
$67K
$116K ﹤0.01%
400,000
– –
DFSCW
162
DEFSEC Technologies Warrant
DFSCW
$63.1K
$108K ﹤0.01%
+120,000
New +$108K
HSCSW icon
163
HeartSciences Inc Warrant
HSCSW
$67.4K
$101K ﹤0.01%
352,941
– –
APCXW
164
DELISTED
AppTech Payments Corp Warrant
APCXW
$100K ﹤0.01%
715,000
– –
CINGW icon
165
Cingulate Inc Warrants
CINGW
$31.8K
$86.1K ﹤0.01%
410,000
– –
BIAFW icon
166
bioAffinity Technologies
BIAFW
$112K
$85.7K ﹤0.01%
204,082
– –
ACONW icon
167
Aclarion Warrant
ACONW
$49K
$85.3K ﹤0.01%
550,000
– –
NXGLW icon
168
NexGel Inc Warrant
NXGLW
$31.4K
$82.5K ﹤0.01%
550,000
– –
SWAGW icon
169
Stran & Company Warrant
SWAGW
$108K
$81.6K ﹤0.01%
545,000
– –
GROY.WS
170
DELISTED
Gold Royalty Corp. Warrants, each warrant exercisable for one common share at an exercise price of $7.50
GROY.WS
$80.6K ﹤0.01%
448,000
– –
NEXRW
171
Nexera Technologies Ltd Warrant
NEXRW
$41.4K
$79.3K ﹤0.01%
480,769
– –
RVSNW icon
172
Rail Vision Ltd Warrant
RVSNW
$793K
$76.2K ﹤0.01%
1,089,500
– –
NXLIW
173
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$65K ﹤0.01%
325,000
– –
BNCWW
174
CEA Industries Inc Warrant
BNCWW
$44.7K
$63K ﹤0.01%
700,000
– –
AGRIW
175
DELISTED
AgriFORCE Growing Systems Ltd Warrant
AGRIW
$51.2K ﹤0.01%
600,000
– –
5 6
7
8 9

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Armistice Capital held 258 positions worth $5.73B, down 0.57% from $5.76B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Armistice Capital withdrew a net $304M in Q4 2022, closing 64 positions and reducing 51 holdings. Its most notable exit was Five Below, an estimated $76.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Armistice Capital opened a new position in CVS Health worth $44.4M.

  • Armistice Capital's largest Q4 2022 buy was CVS Health: 476,000 shares worth $44.4M.
  • Armistice Capital added most to Mirati Therapeutics, Inc. Common Stock in Q4 2022, an estimated $103M increase.
  • Armistice Capital's biggest Q4 2022 reduction was Madrigal Pharmaceuticals, cutting an estimated $101M.
  • Armistice Capital fully exited Five Below in Q4 2022, selling an estimated $76.2M.
  • Armistice Capital's ten largest holdings make up 53% of its $5.73B portfolio in Q4 2022.
  • Armistice Capital opened 61 new positions and closed 64 in Q4 2022.
  • Armistice Capital's portfolio value fell 0.57% quarter-over-quarter to $5.73B.

Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.